Company intelligence / Profile preview

FlowShield-Nano

Ownership: Private
Development stage: Preclinical

Overview

FlowShield-Nano has developed advanced biosensors that provide real-time data on bacterial and heavy metal contamination in beverage manufacturing. Their system aims to enhance quality control by delivering timely alerts to manufacturers. As of 2025, they have completed prototype development, secured early customer interest including a letter of support from a local manufacturer for pilot testing, won innovation competitions, filed patents, and are preparing for broader market pilots.

Modalities: DeviceBiosensor
Industry: Food & Nutrition

Partnerships

Letter of support from local beverage manufacturerparticipated in AMMP Accelerator

Beyond the preview

Go deeper on FlowShield-Nano.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FlowShield-Nano.

Explore the full profile